Financials

  • Market Capitalization 217.03 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.53
Fiyat/satışlar oranı
8.08

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3451
KROS
Keros Therapeutics, Inc. - common stock
11.48 USD-1.12%-0.17%+3.42%-23.97%227.62 M USD
3469
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.74 USD-1.44%+0.37%+4.58%-6.16%220.77 M USD
3479
STRO
Sutro Biopharma, Inc. - Common Stock
12.87 USD-3.09%-12.27%-24.69%-25.99%213.40 M USD
3494
TRDA
Entrada Therapeutics, Inc. - Common Stock
5.33 USD-3.09%-0.93%-21.62%-23.53%207.53 M USD